The ROE as of December 2025 (TTM) for Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) is -10.90%

According to Gwo Xi Stem Cell Applied Technology Co. , Ltd’s latest financial reports and current stock price. The company's current ROE is -10.90%. This represents a change of 72.45% compared to the average of -6.32% of the last 4 quarters.

Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) Historical ROE (quarterly & annually)

How has 6704.TWO ROE performed in the past?

The mean historical ROE of Gwo Xi Stem Cell Applied Technology Co. , Ltd over the last ten years is -16.10%. The current -10.90% ROE has changed -32.28% with respect to the historical average. Over the past ten years (40 quarters), 6704.TWO's ROE was at its highest in in the June 2019 quarter at 0%. The ROE was at its lowest in in the December 2021 quarter at -10.94%.

Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) ROE by Quarter and Year

Discovering the peaks and valleys of Gwo Xi Stem Cell Applied Technology Co. , Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) Average ROE

How has 6704.TWO ROE performed in the past?

The current ROE of Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) ROE vs. Peers

How is 6704.TWO’s ROE compared to its peers?

Gwo Xi Stem Cell Applied Technology Co. , Ltd’s ROE is greater than TaiRx, Inc. (-23.22%), greater than Steminent Biotherapeutics Inc. (-50.04%), greater than Anti-Microbial Savior BioteQ Co., Ltd (-41.50%), less than HeXun Biosciences Co., Ltd. (25.45%), greater than GlycoNex Incorporation (-19.51%), greater than Taiwan Bio Therapeutics Co., Ltd (-42.93%), greater than Intech Biopharm Corporation (-35.97%), greater than Hcmed (-68.42%), greater than Sinew Pharma Inc. (-12.12%), greater than Advagene Biopharma Co., Ltd. (-34.85%),

Build a custom stock screener for Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gwo Xi Stem Cell Applied Technology Co. , Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gwo Xi Stem Cell Applied Technology Co. , Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.